# EDGAR Filing Document

**Accession Number:** 0002043476
**File Stem:** 0001420506-25-002313
**Filing Date:** 2025-8
**Character Count:** 6409
**Document Hash:** a36f49ed920416ab768dd36d7cf94748
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001420506-25-002313.hdr.sgml**: 20250821

**ACCESSION NUMBER**: 0001420506-25-002313

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250821

**EFFECTIVENESS DATE**: 20250821

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** B Group, Inc.
- **CENTRAL INDEX KEY:** 0002043476

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** KS
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-25141
- **FILM NUMBER:** 251239973

**BUSINESS ADDRESS:**
- **STREET 1:** 2900 MCKINNON STREET
- **STREET 2:** SUITE 1101
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75201
- **BUSINESS PHONE:** 469-436-3669 EXT 501

**MAIL ADDRESS:**
- **STREET 1:** 2900 MCKINNON STREET
- **STREET 2:** SUITE 1101
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75201

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0002043476

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** B Group, Inc.

**Address:** 2900 MCKINNON STREET, DALLAS, TX 75201

**Telephone number:** 469-436-3669 EXT 501

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-25141

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER              | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                              | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| Adma Biologics Inc          | 000899104 | 6/4/2025       | Advisory vote to approve named executive officer compensation | SECTION 14A SAY-ON-PAY VOTES |        2316064 |                0 | FOR         |                                  2316064 | FOR                         |  |
| Apogee Therapeutics         | 03770N101 | 6/17/2025      | Advisory vote to approve named executive officer compensation | SECTION 14A SAY-ON-PAY VOTES |            291 |                0 | FOR         |                                      291 | FOR                         |  |
| Aura Biosciences            | 05153U107 | 6/17/2025      | Advisory vote to approve named executive officer compensation | SECTION 14A SAY-ON-PAY VOTES |         450467 |                0 | FOR         |                                   450467 | FOR                         |  |
| Cellectis                   | 15117K103 | 6/26/2025      | Advisory vote to approve named executive officer compensation | SECTION 14A SAY-ON-PAY VOTES |           1050 |                0 | FOR         |                                     1050 | FOR                         |  |
| Insmed Inc                  | 457669307 | 5/15/2025      | Advisory vote to approve named executive officer compensation | SECTION 14A SAY-ON-PAY VOTES |          11110 |                0 | FOR         |                                    11110 | FOR                         |  |
| Iovance Biotherapeutics Inc | 462260100 | 6/10/2025      | Advisory vote to approve named executive officer compensation | SECTION 14A SAY-ON-PAY VOTES |        1023503 |                0 | FOR         |                                  1023503 | FOR                         |  |
| Oruka Therapeutics Inc      | 687604108 | 6/2/2025       | Advisory vote to approve named executive officer compensation | SECTION 14A SAY-ON-PAY VOTES |          33500 |                0 | FOR         |                                    33500 | FOR                         |  |
| Praxis Medicines            | 74006W207 | 6/26/2025      | Advisory vote to approve named executive officer compensation | SECTION 14A SAY-ON-PAY VOTES |          22888 |                0 | FOR         |                                    22888 | FOR                         |  |
| Sight Sciences              | 82657M105 | 6/5/2025       | Advisory vote to approve named executive officer compensation | SECTION 14A SAY-ON-PAY VOTES |         912400 |                0 | FOR         |                                   912400 | FOR                         |  |
| Spyre Therapeutics          | 00773J202 | 5/29/2025      | Advisory vote to approve named executive officer compensation | SECTION 14A SAY-ON-PAY VOTES |          37075 |                0 | FOR         |                                    37075 | FOR                         |  |
| Taysha Gene Therapies       | 877619106 | 6/2/2025       | Advisory vote to approve named executive officer compensation | SECTION 14A SAY-ON-PAY VOTES |         879228 |                0 | FOR         |                                   879228 | FOR                         |  |
| Zai Lab Ltd                 | 98887Q104 | 6/18/2025      | Advisory vote to approve named executive officer compensation | SECTION 14A SAY-ON-PAY VOTES |         194530 |                0 | FOR         |                                   194530 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** B Group, Inc.

**By (Signature):** David Chang

**By (Printed Signature):** David Chang

**By (Title):** Chief Compliance Officer

**Date:** 08/21/2025